Merck
$143.81Change from previous close: −1.03%Absolute change: −$1.50
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $354.8B
- Enterprise value
- $401.62B
- P/E (trailing 12 months)
- 116.0
- Forward P/E
- 15.1
- PEG
- 2.65
- Price/book
- 8.47
- Price/sales
- 5.33
- EV/EBITDA
- 13.9
- EV/revenue
- 6.03
Profitability and growth
- Gross margin
- 75.9%
- Operating margin
- -0.2%
- Net margin
- 4.8%
- ROE
- 7.0%
- ROA
- 11.9%
- Revenue growth (year over year)
- 5.1%
Financial health
- Total cash
- $7.14B
- Total debt
- $53.91B
- Debt/equity
- 1.28
- Current ratio
- 1.32
- Quick ratio
- 0.74
Dividends
- Annual dividend per share
- $3.40
- Dividend yield
- 2.4%
- Payout ratio
- 268.8%
- Ex-dividend date
- September 15, 2026
Analysts and estimates
- Average price target
- $155.76
- Median price target
- $160.00
- High price target
- $186.00
- Low price target
- $105.00
- Analysts with a price target
- 25
- Consensus
- Buy
- Forward EPS
- $9.53
- EPS estimate, current year
- $2.73
Shares and trading
- Beta
- 0.23
- Average volume
- 9.83M
- Shares outstanding
- 2.47B
- Float
- 2.46B
- Institutional ownership
- 83.1%
- Insider ownership
- 0.1%
- Short interest (% of float)
- 1.4%
- Short ratio (days)
- 3.14